Evoq Remedies (BOM:543500) Debt-to-Revenue : 14.14 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Evoq Remedies Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Evoq Remedies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹42.38 Mil. Evoq Remedies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹0.00 Mil. Evoq Remedies's annualized Revenue for the quarter that ended in Mar. 2024 was ₹3.00 Mil. Evoq Remedies's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 14.14.

Evoq Remedies Debt-to-Revenue Historical Data

The historical data trend for Evoq Remedies's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evoq Remedies Debt-to-Revenue Chart

Evoq Remedies Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Revenue

Get a 7-Day Free Trial

0.49

0.47

1.05

Evoq Remedies Semi-Annual Data
	Mar19	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Debt-to-Revenue	Get a 7-Day Free Trial				0.34	0.34	1.04	0.16	14.14

Competitive Comparison of Evoq Remedies's Debt-to-Revenue

For the Medical Distribution subindustry, Evoq Remedies's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evoq Remedies's Debt-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Evoq Remedies's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Evoq Remedies's Debt-to-Revenue falls into.

Evoq Remedies Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Evoq Remedies's Debt-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(42.382	+	0)	/	40.525
	=	1.05

Evoq Remedies's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(42.382	+	0)	/	2.998
	=	14.14

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Mar. 2024) Revenue data.

Evoq Remedies Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Evoq Remedies's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Evoq Remedies (BOM:543500) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Evoq Remedies Ltd (BOM:543500) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Science City Road, A-1106, Empire Business Hub, Near AUDA Water Tank, Sola, Ahmedabad, GJ, IND, 380060

Website

http://www.evoqremedies.com

Evoq Remedies Ltd is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, calcium, multivitamins, injections and others. It operates in a single segment that is Pharmaceutical Trading.

Evoq Remedies (BOM:543500) Headlines

No Headlines